Phase II trial of gemcitabine/carboplatin followed by paclitaxel in patients with performance status = 2,3 or other significant co-morbidity (HIV infection or s/p organ transplantation) in advanced non-small cell lung cancer

Lung Cancer

Volumn 61, Issue 1, 2008, Pages 61-66

  Bridges, Benjamin B ^a   Thomas, Leno ^a   Hausner, Petr F ^a   Doyle, L Austin ^a   Bedor, Michelle ^a   Smith, Ruth ^a   Brahmer, Julie ^b   Edelman, Martin J ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Chemotherapy; Clinical trial; Immunocompromised; Lung cancer; Poor performance status

Indexed keywords

CARBOPLATIN; GEMCITABINE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ANOREXIA; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; BACKACHE; BRAIN METASTASIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONSTIPATION; CONTROLLED STUDY; COUGHING; DEHYDRATION; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; DYSPNEA; EPISTAXIS; FATIGUE; FEMALE; FEVER; HEMOPTYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOALBUMINEMIA; INFECTION; INSOMNIA; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA; NEUROPATHY; NEUTROPENIA; ORGAN TRANSPLANTATION; PHASE 2 CLINICAL TRIAL; PLEURA EFFUSION; PRIORITY JOURNAL; RASH; THORAX PAIN; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; DEOXYCYTIDINE; FEMALE; HIV INFECTIONS; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PACLITAXEL;

EID: 45649083368     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.11.009     Document Type: Article

References (18)

1. Rapp E., Pater J.L., Willan A., Cormier Y., Murray N., Evans W.K., et al. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer-report of a Canadian multicenter randomized trial. J Clin Oncol 6 April (4) (1988) 633-641
2. Schiller J.H., Harrington D., Belani C.P., Langer C., Sandler A., Krook J., et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346 January (10) (2002) 92-98
3. Sandler A., Gray R., Perry M.C., Brahmer J., Schiller J.H., Dowlati A., et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355 December (24) (2006) 2542-2550
4. Sweeney C.J., Zhu J., Sandler A.B., Schiller J., Belani C.P., Langer C., et al. Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma. Cancer 92 November (10) (2001) 2639-2647
5. Lilenbaum R.C., Herndon II J.E., List M.A., Desch C., Watson D.M., Miller A.A., et al. Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). J Clin Oncol 23 (2005) 190-196
6. Langer C., Li S., Schiller J., Tester W., Rapoport B.L., and Johnson D.H. Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599. J Clin Oncol 25 February (4) (2007) 418-423
7. Engels E.A., Brock M.V., Chen J., Hooker C.M., Gillison M., and Moore R.D. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol 24 March (9) (2006) 1383-1388
8. Bellil Y., and Edelman M.J. Bronchogenic carcinoma in solid organ transplant recipients. Curr Treat Options Oncol 7 January (1) (2006) 77-81
9. Oo Y.H., Gunson B.K., Lancashire R.J., Cheng K.K., and Neuberger J.M. Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation 80 September (6) (2005) 759-764
10. Hakimian R., Fang H., Thomas L., and Edelman M.J. Lung cancer in HIV infected patients in the era of highly active antiretroviral therapy. J Thorac Oncol 2 April (4) (2007) 268-727
11. Tirelli U., Spina M., Sandri S., Serraino D., Gobitti C., Fasan M., et al. Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors. Cancer 88 February (3) (2000) 563-569
12. Edelman M.J., Gandara D.R., Lau D., Lara P., Lauder J., and Tracy D. Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxel. Cancer 92 July (1) (2001) 146-152
13. Edelman M.J., Gandara D.R., Lau D., and Lauder I. Sequential chemotherapy with carboplatin and gemcitabine followed by placlitaxel in poor performance status and elderly patients with non-small cell lung cancer. Lung Cancer 29 September (Suppl 1) (2000) 16 [Ninth World Conference on Lung Cancer, Tokyo]
14. Akerley W., Herndon Jr. J.E., Lyss A.P., Choy H., Turrisi A., Graziano S., et al. Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B. Cancer 97 May (10) (2003) 2480-2486
15. Shepherd F.A., Rodrigues Pereira J., Ciuleanu T., Tan E.H., Hirsh V., Thongprasert S., et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353 July (2) (2005) 123-132
16. Edelman M.J., Clark J., Chansky K., Albain K., and Gandara D.R. Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel. Clin Cancer Res 10 August (15) (2004) 5022-5026
17. Fidias P., Dakhil S., Lyss A., Loesch D., Watherhouse D., Cunneen J., et al. Phase III study of immediate versus delayed docetaxel after induction therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer: Updates report with survival. ASCO Annual Meeting Proceedings Part I Vol. 25: No. 18S LBA7516. J Clin Oncol June (Suppl) (2007)
18. Hesketh P.J., Chansky K., Lau D.H., Doroshow J.H., Moinpour C.M., Chapman R.A., et al. Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027). J Thorac Oncol 1 6 (2006) 537-544